Medicinova (MNOV) Gains from Investment Securities (2021 - 2025)
Medicinova (MNOV) has disclosed Gains from Investment Securities for 8 consecutive years, with -$199.0 as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities changed N/A to -$199.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Sep 2025, down 5.47% year-over-year, with the annual reading at $9.9 million for FY2025, 5017358.08% up from the prior year.
- Gains from Investment Securities for Q4 2025 was -$199.0 at Medicinova, down from $7.9 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $8.7 million in Q1 2023, with the low at -$5142.0 in Q4 2021.
- Average Gains from Investment Securities over 5 years is $4.4 million, with a median of $4.6 million recorded in 2025.
- The sharpest move saw Gains from Investment Securities skyrocketed 1528.05% in 2023, then crashed 97.48% in 2024.
- Over 5 years, Gains from Investment Securities stood at -$5142.0 in 2021, then soared by 155394.63% to $8.0 million in 2022, then crashed by 96.98% to $241514.0 in 2023, then skyrocketed by 3361.43% to $8.4 million in 2024, then plummeted by 100.0% to -$199.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$199.0, $7.9 million, and $512000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.